Lung Cancer Clinical Trial
Piloting ‘mPal,’ a Multilevel Strategy for Palliative Care Implementation
Summary
The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.
Full Description
In this study, 60 advanced stage lung cancer patients will be randomized to mPal's patient-level component or usual care. Oncology providers will receive the mPal intervention. mPal is designed to help oncology providers integrate outpatient palliative care (non-hospice palliative care; NHPC) into routine clinical practice through: 1) electronic health record enhancements; 2) patient education and preparation for NHPC discussions when patients are in clinic to see their oncology providers; and 3) provider education about NHPC.
This study will examine the feasibility and acceptability of mPal and gather preliminary data on potential outcomes for a future effectiveness trial.
Eligibility Criteria
Inclusion Criteria:
new or recurrent AJCC stage IIIb-IV non-small cell lung cancer or extensive stage small cell lung cancer
ECOG performance status 0-3/Karnofsky 40-100
at least three weeks into active oncologic treatment (chemotherapy, immunotherapy, chemo-immunotherapy)
Exclusion Criteria:
unstable brain metastases
Cognitive (i.e., dementia) or psychiatric condition (e.g., psychotic disorder) for which participating would be inappropriate
Receiving palliative care
Unable to speak and read English
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?